About this trial
The goal of this observational study is to investigate and describe the injury patterns, secondary complications, and biomechanical properties of the upper limb during the initial 6 months post-SCI.
The overarching objective is to investigate and describe the trajectory of upper limb functioning, secondary complications, and biomechanical properties of the upper limb during the initial 6 months post-SCI and explore factors influencing functional use of the hands at 6 months after injury.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Signed informed consent
Acute onset Cervical SCI (traumatic and non-traumatic) C0-C7 AIS A-D that affects motor function in the upper limb.
Over the age of 18 at admission
Admitted for rehabilitation at one of the study sites.
Disqualifiers
For the surveys: Inability to understand Swedish or English in writing.
Trial population
All individuals with acute onset cervical SCI (traumatic and non-traumatic) C0-C7 AIS A-D that affects motor function in the upper limb at the following study sites will be invited; In Sweden; Region Skåne, Region Västerbotten, Region Stockholm, Västra Götalandsregionen. In New Zealand, the two national spinal units in Auckland and Christchurch. In Canada: Lyndhurst Toronto rehab, KITE, Toronto.
Trial design
Cohort
Prospective
Treatments tested in this trial
Assessment of upper limb function
Other interventionObservational study of the changes in upper limb after SCI paralysis
Treatment groups
Trial outcomes
Primary outcomes
Motor neuron testing
Motor neuron testing, using the well established NeuroMuscular Electrical Stimulation (NMES). Identification of the LMN integrity in defined muscle will be done by surface electrical stimulation of the forearm according to standardized technique (Bersch 2018). A standard four-channel nerve stimulator ( Chattanooga Rehab SKU 2533110-INT) will be used and with stimulation parameters according to international recommendations for nerve/muscle stimulation; 20-80 mA, 250-300 μs at 35 Hz (Bersch 2022). All stimulators have CE approval, approved as medical technical product (medicinteknisk produkt) in Sweden and manuals in both Swedish and English are available. The stimulator will be used within approved area.
Other outcomes
International Standards for Neurological Classification of SCI (ISNCSCI) including the American Spinal Injury Association Impairment Scale (AIS)
ISNCSCI and AIS are well-established international communication tools for researchers and clinicians to quantify the neurological impairment resulting from a spinal cord injury. (Kirshblum 2011) The ISNCSCI examine the motor- and sensory level of injury, C1- C7. While the AIS describe the completeness of the injury using a 5-point ordinal scale, classifying individuals from A" (complete SCI) to "E" (normal sensory and motor function) The ISNCSCI and AIS is part of clinical routine at admission and discharge
Muscle strength
Active motor strength, as measured by the Medical Research Council are considered golden standard for muscle testing.
Modified Ashworth scale
Modified Ashworth scale (Baunsgaard 2016) is considered one of the golden standard measures in measuring spasticity in SCI. The scale go from 0-5 where 0=no spasticity and 5=rigid.
Biomechanical balance of the hand
Observation of the maximal hand opening and closing.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Vastra Gotaland Region
Lead sponsor
Promobilia Foundation
Collaborator
This trial is not recruiting at the moment. You can still explore other options: